Immunic Statistics

Total Valuation

Immunic has a market cap or net worth of $67.07 million. The enterprise value is $53.74 million.

Market Cap	67.07M
Enterprise Value	53.74M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025, before market open.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Immunic has 95.82 million shares outstanding. The number of shares has increased by 75.28% in one year.

Current Share Class	95.82M
Shares Outstanding	95.82M
Shares Change (YoY)	+75.28%
Shares Change (QoQ)	+0.64%
Owned by Insiders (%)	1.77%
Owned by Institutions (%)	26.45%
Float	76.27M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.74

Current Ratio	0.74
Quick Ratio	0.63
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -246.26% and return on invested capital (ROIC) is -157.03%.

Return on Equity (ROE)	-246.26%
Return on Assets (ROA)	-101.26%
Return on Invested Capital (ROIC)	-157.03%
Return on Capital Employed (ROCE)	1,989.29%
Revenue Per Employee	n/a
Profits Per Employee	-$1.06M
Employee Count	91
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.62% in the last 52 weeks. The beta is 1.49, so Immunic's price volatility has been higher than the market average.

Beta (5Y)	1.49
52-Week Price Change	-28.62%
50-Day Moving Average	0.91
200-Day Moving Average	1.13
Relative Strength Index (RSI)	35.47
Average Volume (20 Days)	2,752,559

Short Selling Information

The latest short interest is 7.44 million, so 7.77% of the outstanding shares have been sold short.

Short Interest	7.44M
Short Previous Month	4.25M
Short % of Shares Out	7.77%
Short % of Float	9.76%
Short Ratio (days to cover)	3.59

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-101.00M
Pretax Income	-95.31M
Net Income	-96.40M
EBITDA	-100.85M
EBIT	-101.00M
Earnings Per Share (EPS)	-$0.95

Full Income Statement

Balance Sheet

The company has $14.30 million in cash and $975,000 in debt, giving a net cash position of $13.33 million or $0.14 per share.

Cash & Cash Equivalents	14.30M
Total Debt	975,000
Net Cash	13.33M
Net Cash Per Share	$0.14
Equity (Book Value)	-5.29M
Book Value Per Share	-0.06
Working Capital	-6.62M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$82.57 million and capital expenditures -$280,000, giving a free cash flow of -$82.85 million.

Operating Cash Flow	-82.57M
Capital Expenditures	-280,000
Free Cash Flow	-82.85M
FCF Per Share	-$0.86

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Immunic does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-75.28%
Shareholder Yield	-75.28%
Earnings Yield	-143.72%
FCF Yield	-123.53%

Analyst Forecast

The average price target for Immunic is $11.60, which is 1,557.14% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.60
Price Target Difference	1,557.14%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1